CoYoT1 to California

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 20, 2019

Primary Completion Date

July 28, 2022

Study Completion Date

December 31, 2022

Conditions
Type 1 Diabetes Mellitus
Interventions
BEHAVIORAL

CoYoT1 Care

Selected providers will be trained in the CoYoT1 Care protocol for completing medical appointments (both telehealth/standard appointments). There are three key components: (1) Shared decision making: Providers and YA will mutually agree on priorities for each medical visit using a shared decision making tool completed by both the provider and patient. (2) Autonomy supportive care: Providers will be trained in communication strategies, such as motivational interviewing, designed to support YA autonomy and intrinsic motivation. YA will also direct extent of eligible family involvement. (3) Goal setting and action planning: Providers will be trained to coach YA in setting SMART goals, developing action plans, and establishing a plan for follow-up between visits as appropriate.

OTHER

Standard Care

"Providers selected for the Standard Care group will complete medical appointments in their usual manner, without specific training or guidelines regarding how to deliver care.~NOTE: Per COVID-19 hospital policies, current clinic appointments consist of telehealth appointments."

Trial Locations (1)

90027

Children's Hospital, Los Angeles

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

Rutgers University

OTHER

lead

Children's Hospital Los Angeles

OTHER

NCT03793673 - CoYoT1 to California | Biotech Hunter | Biotech Hunter